ZYMOGENETICS, INC. | Bristol-Myers Squibb | Washington | state | 2017 | $5,971,568 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $333,589 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2005 | $181,604 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $113,958 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $88,277 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2008 | $120,165 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2009 | $127,860 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $95,385 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $3,872 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $12,368 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $143,394 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $481,822 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2005 | $375,100 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $380,245 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $518,618 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2008 | $474,786 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2009 | $351,337 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $143,394 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $298,738 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $19,311 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $102,839 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $1,441 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $102,839 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2014 | $102,925 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2015 | $102,925 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2016 | $102,839 | | tax credit/rebate |
Zoetis, LLC | Zoetis | Nebraska | state | 2014 | undisclosed | | tax credit/rebate |
Zoetis, LLC | Zoetis | Nebraska | state | 2022 | $789,317 | | tax rebate |
Zoetis, Inc. and Subsidiaries | Zoetis | Iowa | State | 2017 | $2,499,000 | | Tax credit |
Zoetis Inc. and Subsidiaries | Zoetis | New Jersey | state | 2012 | $19,250,000 | | grant |
Wyeth-Lederle (#2) | Pfizer | North Carolina | state | 2004 | $500,000 | | grant |
Wyeth-Ayerst Pharmaceuticals | Pfizer | Pennsylvania | state | | $500,000 | | grant |
Wyeth-ayerst Laboratories Inc. | Pfizer | Michigan | state | 1995 | undisclosed | | property tax abatement |
Wyeth, Inc. | Pfizer | United States | federal | 2019 | | $3,542,000 | federal loan or loan guarantee |
Wyeth Pharmaceuticals, Inc. | Pfizer | Pennsylvania | state | | $500,000 | | grant |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2013 | $1,058 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2016 | $3,214 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2015 | $3,442 | | tax credit/rebate |
Wyeth Pharmaceuticals | Pfizer | Virginia | state | 2004 | $2,000,000 | | grant |
Wyeth Holdings LLC | Pfizer | North Carolina | state | 2019 | $125,000 | | grant |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2009 | $2,868,194 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2010 | $373,801 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2008 | $18,128,934 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2009 | $1,653,115 | | tax credit/rebate |
WYETH HOLDINGS CORPORATION | Pfizer | New York | local | 2009 | $280,900 | | tax credit/rebate; property tax abatement |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2011 | $189,498 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2012 | $218,644 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $272,967 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $4,097,786 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $3,476,438 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $143,193 | | tax credit/rebate |
Wyeth | Pfizer | Pennsylvania | state | 2008 | $802,021 | | tax credit/rebate |
Wyeth | Pfizer | Pennsylvania | state | 2009 | $154,958 | | tax credit/rebate |
Watson Pharmaceuticals, Inc. and Affiliates | Teva Pharmaceutical Industries | New Jersey | state | 2009 | $3,038,000 | | grant |
WATSON PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | California | state | 2005 | $32,240 | | training reimbursement |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | New Jersey | state | 2011 | $569,910 | | grant |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | New Jersey | state | 2010 | $289,800 | | tax credit/rebate |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | Mississippi | state | 2012 | $50,000 | | training reimbursement |
WATSON LABORATORIES, INC. | Teva Pharmaceutical Industries | California | state | 2003 | $166,452 | | training reimbursement |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Utah | state | 2009 | $7,450 | | training reimbursement |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Florida | state | 2000 | $312,000 | | tax credit/rebate |
Warner-lambert Company, LLC | Pfizer | Michigan | state | 2010 | undisclosed | | property tax abatement |
WARNER-LAMBERT COMPANY (PD DIV) | Pfizer | Michigan | local | 1992 | undisclosed | | property tax abatement |
WARNER-LAMBERT COMPANY | Pfizer | Michigan | local | 1992 | undisclosed | | property tax abatement |
WARNER-LAMBERT COMPANY | Pfizer | Michigan | local | 2002 | undisclosed | | property tax abatement |
WARNER-LAMBERT COMPANY | Pfizer | Michigan | local | 2004 | undisclosed | | property tax abatement |
WARNER-LAMBERT COMPANY | Pfizer | Michigan | local | 2006 | undisclosed | | property tax abatement |
WARNER LAMBERT COMPANY/PARKE DAVIS DIVISION | Pfizer | Michigan | local | 1992 | undisclosed | | property tax abatement |
WARNER LAMBERT COMPANY | Pfizer | Michigan | local | 1992 | undisclosed | | property tax abatement |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2012 | $98,234 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2013 | $36,899 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2014 | $83,843 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2011 | $81,973 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2010 | $61,206 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2009 | $100,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2008 | $100,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2015 | $80,382 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2016 | $269,391 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2017 | $726,780 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc | AbbVie | Pennsylvania | state | | $10,000 | | tax credit/rebate |
VISX, Inc | Abbott Laboratories | California | state | 2004 | undisclosed | | training reimbursement |
VISX INCORPORATED | Abbott Laboratories | California | state | 2006 | $59,748 | | training reimbursement |
Viropharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | | $453,000 | | tax credit/rebate |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,152,515 | | tax credit/rebate |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,271,658 | | tax credit/rebate |
Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals | Massachusetts | state | 2012 | $880,128 | | tax credit/rebate |
Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals | Massachusetts | state | 2012 | $1,568,471 | | tax credit/rebate |
Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals | Massachusetts | state | 2011 | undisclosed | | tax credit/rebate |
VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | Vertex Pharmaceuticals | California | state | 2019 | $16,570 | | training reimbursement |
Vertex Pharmaceuticals | Vertex Pharmaceuticals | Massachusetts | multiple | 2011 | $72,000,000 | | MEGADEAL (Archived) |
Vertex Pharmaceuticals | Vertex Pharmaceuticals | Massachusetts | local | 2015 | $9,000,000 | | tax increment financing |
Versum Materials, Inc. | Merck KGaA (EMD) | Arizona | state | 2017 | $2,100,000 | | tax credit/rebate |
VERSUM MATERIALS INC | Merck KGaA (EMD) | Pennsylvania | state | 2020 | $16,500 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2010 | $16,124 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2011 | $55,480 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2012 | $28,896 | | tax credit/rebate |
Ventana USA | Roche | Pennsylvania | state | | $28,836 | | training reimbursement |
Ventana USA | Roche | Pennsylvania | state | | $25,000 | | tax credit/rebate |
Ventana USA | Roche | Pennsylvania | state | 2013 | $12,320 | | tax credit/rebate |
VENTANA USA | Roche | Pennsylvania | state | 2020 | $4,200 | | tax credit/rebate |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2005 | $443,248 | | training reimbursement |